Log In
BCIQ
Print this Print this
 

ONCOS-402

  Manage Alerts
Collapse Summary General Information
Company Targovax A/S
DescriptionOncolytic virus based on serotype 5/3 adenovirus coding for CD40 ligand
Molecular Target CD40 ligand (CD40L) (CD40LG) (CD154)
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today